首页> 美国卫生研究院文献>Human Molecular Genetics >Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration
【2h】

Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration

机译:神经病性高雪氏病小鼠模型中葡萄糖神经酰胺的神经元蓄积导致神经退行性变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gaucher disease has recently received wide attention due to the unexpected discovery that it is a genetic risk factor for Parkinson's disease. Gaucher disease is caused by the defective activity of the lysosomal enzyme, glucocerebrosidase (GCase; GBA1), resulting in intracellular accumulation of the glycosphingolipids, glucosylceramide and psychosine. The rare neuronopathic forms of GD (nGD) are characterized by profound neurological impairment and neuronal cell death. We have previously described the progression of neuropathological changes in a mouse model of nGD. We now examine the relationship between glycosphingolipid accumulation and initiation of pathology at two pre-symptomatic stages of the disease in four different brain areas which display differential degrees of susceptibility to GCase deficiency. Liquid chromatography electrospray ionization tandem mass spectrometry demonstrated glucosylceramide and psychosine accumulation in nGD brains prior to the appearance of neuroinflammation, although only glucosylceramide accumulation correlated with neuroinflammation and neuron loss. Levels of other sphingolipids, including the pro-apoptotic lipid, ceramide, were mostly unaltered. Transmission electron microscopy revealed that glucosylceramide accumulation occurs in neurons, mostly in the form of membrane-delimited pseudo-tubules located near the nucleus. Highly disrupted glucosylceramide-storing cells, which are likely degenerating neurons containing massive inclusions, numerous autophagosomes and unique ultrastructural features, were also observed. Together, our results indicate that a certain level of neuronal glucosylceramide storage is required to trigger neuropathological changes in affected brain areas, while other brain areas containing similar glucosylceramide levels are unaltered, presumably because of intrinsic differences in neuronal properties, or in the neuronal environment, between various brain regions.
机译:由于出乎意料的发现它是帕金森氏病的遗传危险因素,戈谢病已引起广泛关注。高雪氏病是由溶酶体酶,葡糖脑苷脂酶(GCase; GBA1)的活性缺陷引起的,导致糖鞘脂,葡糖神经酰胺和精神病菌在细胞内积累。 GD(nGD)的罕见神经病变形式的特征是严重的神经功能障碍和神经元细胞死亡。我们先前已经描述了nGD小鼠模型中神经病理学变化的进程。现在,我们在四个不同的大脑区域(显示对GCase缺乏症的敏感性程度不同)在疾病的两个症状前阶段,检查糖鞘脂积聚与病理学启动之间的关系。液相色谱电喷雾电离串联质谱分析表明,在出现神经炎症之前,nGD大脑中存在糖基神经酰胺和神经氨酸的积累,尽管只有糖基神经酰胺的积累与神经炎症和神经元的丢失有关。其他鞘脂的水平,包括促凋亡脂质神经酰胺,大部分没有改变。透射电子显微镜显示,葡糖神经酰胺积累发生在神经元中,主要以位于细胞核附近的膜定界假小管的形式出现。还观察到高度破坏的葡糖神经酰胺储存细胞,其可能是退化的神经元,其包含大量包涵体,许多自噬体和独特的超微结构特征。总之,我们的结果表明,需要一定水平的神经元葡萄糖神经酰胺存储来触发受影响的大脑区域的神经病理变化,而其他包含相似葡萄糖神经酰胺水平的大脑区域则保持不变,这可能是由于神经元特性或神经环境中的内在差异所致,在各个大脑区域之间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号